Epidemiology of Behcet’s Disease in Taiwan: A Population-Based Study

References

• Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behcet’s disease: a comprehensive review. J Autoimmun. 2015;64:137–148. doi:10.1016/j.jaut.2015.08.013.
   PubMed Web of Science ®Google Scholar
• International Team for the Revision of the International Criteria for Behcet’s D. The international criteria for Behcet’s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–347. doi:10.1111/jdv.12107.
   PubMed Web of Science ®Google Scholar
• Yurdakul S, Yazici H. Behcet’s syndrome. Best Pract Res Clin Rheumatol. 2008;22(5):793–809. doi:10.1016/j.berh.2008.08.005.
   PubMed Web of Science ®Google Scholar
• Keino H, Okada AA. Behcet’s disease: global epidemiology of an old silk road disease. Br J Ophthalmol. 2007;91(12):1573–1574. doi:10.1136/bjo.2007.124875.
   PubMed Web of Science ®Google Scholar
• Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behcet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175–1183. doi:10.1136/bjo.87.9.1175.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Pipitone N, Catanoso MG, et al. Epidemiology and clinical course of Behcet’s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum. 2007;57(1):171–178. doi:10.1002/art.22500.
   PubMed Web of Science ®Google Scholar
• Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behcet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61(5):600–604. doi:10.1002/art.24423.
   PubMed Web of Science ®Google Scholar
• Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58(12):3951–3959. doi:10.1002/art.24149.
   PubMed Web of Science ®Google Scholar
• Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26(4):555–560. doi:10.1007/s10067-006-0349-4.
   PubMed Web of Science ®Google Scholar
• Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42(10):803–806. doi:10.1046/j.1365-4362.2003.01893.x.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Jamshidi AR, Banihashemi AT, et al. WHO-ILAR COPCORD study (Stage 1, Urban Study) in Iran. J Rheumatol. 2008;35(7):1384.
   PubMed Web of Science ®Google Scholar
• Al-Rawi ZS, Neda AH. Prevalence of Behcet’s disease among Iraqis. Adv Exp Med Biol. 2003;528:37–41.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Duftner C, Calamia KT, Schirmer M. 13th international conference on Behcet’s Disease, May 24- 27,2008, Portschach am Worthersee, Austria. J Rheumatol. 2009;36(6):1312–1317. doi:10.3899/jrheum081008.
   PubMedGoogle Scholar
• Mohammad A, Mandl T, Sturfelt G, Segelmark M. Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology (Oxford). 2013;52(2):304–310. doi:10.1093/rheumatology/kes249.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet’s disease: from East to West. Clin Rheumatol. 2010;29(8):823–833. doi:10.1007/s10067-010-1430-6.
   PubMed Web of Science ®Google Scholar
• Borlu M, Uksal U, Ferahbas A, Evereklioglu C. Clinical features of Behcet’s disease in children. Int J Dermatol. 2006;45(6):713–716. doi:10.1111/ijd.2006.45.issue-6.
   PubMed Web of Science ®Google Scholar
• Criteria for diagnosis of Behcet’s disease. International study group for Behcet’s disease. Lancet. 1990;335(8697):1078–1080.
   PubMed Web of Science ®Google Scholar
• Kone-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behcet’s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132(4):721–725. doi:10.1016/S0022-3476(98)70368-3.
   PubMed Web of Science ®Google Scholar
• Onder M, Gurer MA. The multiple faces of Behcet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol. 2001;15(2):126–136. doi:10.1046/j.1468-3083.2001.00251.x.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380. doi:10.1016/j.ajo.2004.03.022.
   PubMed Web of Science ®Google Scholar
• Tuzun Y, Yurdakul S, Cem Mat M, et al. Epidemiology of Behcet’s syndrome in Turkey. Int J Dermatol. 1996;35(9):618–620. doi:10.1111/j.1365-4362.1996.tb03683.x.
   PubMed Web of Science ®Google Scholar
• Farah S, Al-Shubaili A, Montaser A, et al. Behcet’s syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry. 1998;64(3):382–384. doi:10.1136/jnnp.64.3.382.
   PubMed Web of Science ®Google Scholar
• Kaklamani VG, Kaklamanis PG. Treatment of Behcet’s disease–an update. Semin Arthritis Rheum. 2001;30(5):299–312. doi:10.1053/sarh.2001.19819.
   PubMed Web of Science ®Google Scholar
• Ozen S. Vasculopathy, Behcet’s syndrome, and familial Mediterranean fever. Curr Opin Rheumatol. 1999;11(5):393–398. doi:10.1097/00002281-199909000-00011.
   PubMedGoogle Scholar
• Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet’s disease. Int J Dermatol. 2003;42(5):346–351. doi:10.1046/j.1365-4362.2003.01741.x.
   PubMed Web of Science ®Google Scholar
• Liu CY, Hung YT, Chuang YL. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:1–22.
   Google Scholar
• Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe. Yonsei Med J. 1997;38(6):411–422. doi:10.3349/ymj.1997.38.6.411.
   PubMedGoogle Scholar
• Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173–183. doi:10.4103/0301-4738.31936.
   PubMedGoogle Scholar
• Hwang DK, Chou YJ, Pu CY, Chou P. Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology. 2012;119(11):2371–2376. doi:10.1016/j.ophtha.2012.05.026.
   PubMed Web of Science ®Google Scholar
• Naugler C, Conrad DM. The hardscrabble hypothesis: a reduction in chronic tissue damage has increased the incidence of autoimmune disease. Med Hypotheses. 2010;74(2):366–367. doi:10.1016/j.mehy.2009.07.004.
   PubMed Web of Science ®Google Scholar
• Mizushima Y. Recent research into Behcet’s disease in Japan. Int J Tissue React. 1988;10(2):59–65.
   PubMedGoogle Scholar
• Tugal-Tutkun I, Gupta V, Cunningham ET. Differential diagnosis of behcet uveitis. Ocul Immunol Inflamm. 2013;21(5):337–350. doi:10.3109/09273948.2013.795228.
   PubMed Web of Science ®Google Scholar
• Kim DY, Choi MJ, Cho S, Kim DW, Bang D. Changing clinical expression of Behcet disease in Korea during three decades (1983-2012): chronological analysis of 3674 hospital-based patients. Br J Dermatol. 2014;170(2):458–461. doi:10.1111/bjd.12661.
   PubMed Web of Science ®Google Scholar
• Kirino Y, Ideguchi H, Takeno M, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet’s disease: a retrospective observational study. Arthritis Res Ther. 2016;18(1):217. doi:10.1186/s13075-016-1115-x.
   PubMed Web of Science ®Google Scholar
• Hamuryudan V, Hatemi G, Tascilar K, et al. Colchicine in Behcet syndrome: a longterm survey of patients in a controlled trial. J Rheumatol. 2014;41(4):735–738. doi:10.3899/jrheum.130847.
   PubMed Web of Science ®Google Scholar
• Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol. 2005;50(4):297–350. doi:10.1016/j.survophthal.2005.04.009.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Silman A, Bang D, et al. Management of Behcet disease: a systematic literature review for the European league against rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis. 2009;68(10):1528–1534. doi:10.1136/ard.2008.087957.
   PubMed Web of Science ®Google Scholar
• Saleh Z, Arayssi T. Update on the therapy of Behcet disease. Ther Adv Chronic Dis. 2014;5(3):112–134. doi:10.1177/2040622314523062.
   PubMedGoogle Scholar
• Turkcu FM, Sahin A, Cingu AK, et al. Serum omentin, resistin and tumour necrosis factor-alpha levels in Behcet patients with and without ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2015;253(9):1565–1568. doi:10.1007/s00417-015-3016-0.
   PubMed Web of Science ®Google Scholar
• Horie Y, Meguro A, Ohta T, et al. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the silk road: a literature survey. Ocul Immunol Inflamm. 2017;25(1):37–40. doi:10.3109/09273948.2015.1136422.
   PubMed Web of Science ®Google Scholar
• Hsieh CY, Chen CH, Li CY, Lai ML. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. J Formos Med Assoc. 2015;114(3):254–259. doi:10.1016/j.jfma.2013.09.009.
   PubMed Web of Science ®Google Scholar
• Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in taiwan. J Epidemiol. 2014;24(6):500–507. doi:10.2188/jea.JE20140076.
   PubMed Web of Science ®Google Scholar